{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T19:12:44Z","timestamp":1792005164300,"version":"4.4.0"},"reference-count":47,"publisher":"Spandidos Publications","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Oncol Lett"],"DOI":"10.3892\/ol.2019.10029","type":"journal-article","created":{"date-parts":[[2019,2,8]],"date-time":"2019-02-08T13:40:51Z","timestamp":1549633251000},"source":"Crossref","is-referenced-by-count":8,"title":["Inhibition of the PI3K\/AKT signaling pathway sensitizes diffuse large B\u2011cell lymphoma cells to treatment with proteasome inhibitors via suppression of BAG3"],"prefix":"10.3892","author":[{"given":"Ting","family":"Yuan","sequence":"first","affiliation":[{"name":"Department of Hematology, Shandong\ufffdProvincial Hospital Affiliated to Shandong\ufffdUniversity, Jinan, Shandong 250021, P.R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feng","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Hematology, Shandong Provincial Hospital Affiliated to Shandong University, Jinan, Shandong 250021, P.R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiangxiang","family":"Zhou","sequence":"additional","affiliation":[{"name":"Department of Hematology, Shandong Provincial Hospital Affiliated to Shandong University, Jinan, Shandong 250021, P.R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Hematology, Shandong Provincial Hospital Affiliated to Shandong University, Jinan, Shandong 250021, P.R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ya","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Hematology, Shandong Provincial Hospital Affiliated to Shandong University, Jinan, Shandong 250021, P.R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yangyang","family":"Xu","sequence":"additional","affiliation":[{"name":"Department of Hematology, Shandong Provincial Hospital Affiliated to Shandong University, Jinan, Shandong 250021, P.R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Hematology, Shandong Provincial Hospital Affiliated to Shandong University, Jinan, Shandong 250021, P.R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2249","published-online":{"date-parts":[[2019,2,8]]},"reference":[{"key":"key20200714085828_b1-ol-0-0-10029","first-page":"3909","article-title":"A clinical evaluation of the International Lymphoma Study Group classification of non-Hodgkin's lymphoma","volume":"89","year":"1997","journal-title":"The non-hodgkin's lymphoma classification project"},{"key":"key20200714085828_b2-ol-0-0-10029","doi-asserted-by":"publisher","first-page":"418","DOI":"10.3945\/an.116.012211","article-title":"World cancer report 2014","volume":"7","author":"McGuire","year":"2016","journal-title":"Adv Nutr"},{"key":"key20200714085828_b3-ol-0-0-10029","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1016\/j.beha.2018.07.014","article-title":"Management of relapsed\/refractory DLBCL","volume":"31","author":"Sarkozy","year":"2018","journal-title":"Best Pract Res Clin Haematol"},{"key":"key20200714085828_b4-ol-0-0-10029","doi-asserted-by":"publisher","DOI":"10.3322\/caac.21357","article-title":"2016 US lymphoid malignancy statistics by World Health Organization subtypes","author":"Teras","year":"2016","journal-title":"CA Cancer J Clin"},{"key":"key20200714085828_b5-ol-0-0-10029","article-title":"Bortezomib. StatPearls [Internet]","author":"Sharma","year":"2018","journal-title":"Treasure Island (FL) StatPearls Publishing"},{"key":"key20200714085828_b6-ol-0-0-10029","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1186\/s12943-015-0474-2","article-title":"Novel drug targets for personalized precision medicine in relapsed\/refractory diffuse large B-cell lymphoma: A comprehensive review","volume":"14","author":"Camicia","year":"2015","journal-title":"Mol Cancer"},{"key":"key20200714085828_b7-ol-0-0-10029","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1016\/j.clml.2018.05.023","article-title":"A phase II trial of bortezomib and vorinostat in mantle cell lymphoma and diffuse large B-cell lymphoma","volume":"18","author":"Yazbeck","year":"2018","journal-title":"Clin Lymphoma Myeloma Leuk"},{"key":"key20200714085828_b8-ol-0-0-10029","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1111\/bjh.12488","article-title":"A phase I\/II trial of bortezomib combined concurrently with gemcitabine for relapsed or refractory DLBCL and peripheral T-cell lymphomas","volume":"163","author":"Evens","year":"2013","journal-title":"Br J Haematol"},{"key":"key20200714085828_b9-ol-0-0-10029","doi-asserted-by":"publisher","first-page":"1092","DOI":"10.1182\/blood-2005-03-1158","article-title":"Antimyeloma activity of heat shock protein-90 inhibition","volume":"107","author":"Mitsiades","year":"2006","journal-title":"Blood"},{"key":"key20200714085828_b10-ol-0-0-10029","doi-asserted-by":"publisher","first-page":"3255","DOI":"10.1182\/blood-2004-10-3984","article-title":"Evidence for a protective role of Mcl-1 in proteasome inhibitor-induced apoptosis","volume":"105","author":"Nencioni","year":"2005","journal-title":"Blood"},{"key":"key20200714085828_b11-ol-0-0-10029","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1016\/j.bbrc.2007.11.001","article-title":"Transcriptional upregulation of BAG3 upon proteasome inhibition","volume":"365","author":"Wang","year":"2008","journal-title":"Biochem Biophys Res Commun"},{"key":"key20200714085828_b12-ol-0-0-10029","doi-asserted-by":"publisher","first-page":"1553","DOI":"10.1126\/science.1057268","article-title":"Structure of a Bag\/Hsc70 complex: Convergent functional evolution of Hsp70 nucleotide exchange factors","volume":"291","author":"Sondermann","year":"2001","journal-title":"Science"},{"key":"key20200714085828_b13-ol-0-0-10029","doi-asserted-by":"publisher","first-page":"5591","DOI":"10.1007\/s13277-015-4403-1","article-title":"BAG3 regulates cell proliferation, migration, and invasion in human colorectal cancer","volume":"37","author":"Shi","year":"2016","journal-title":"Tumour Biol"},{"key":"key20200714085828_b14-ol-0-0-10029","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1007\/s00277-013-1883-1","article-title":"Overexpressed BAG3 is a potential therapeutic target in chronic lymphocytic leukemia","volume":"93","author":"Zhu","year":"2014","journal-title":"Ann Hematol"},{"key":"key20200714085828_b15-ol-0-0-10029","doi-asserted-by":"publisher","first-page":"2504","DOI":"10.1016\/j.ajpath.2011.02.002","article-title":"BAG3 protein is overexpressed in human glioblastoma and is a potential target for therapy","volume":"178","author":"Festa","year":"2011","journal-title":"Am J Pathol"},{"key":"key20200714085828_b16-ol-0-0-10029","doi-asserted-by":"publisher","first-page":"9205","DOI":"10.1074\/jbc.M110.175836","article-title":"BAG3 expression in glioblastoma cells promotes accumulation of ubiquitinated clients in an Hsp70-dependent manner","volume":"286","author":"Gentilella","year":"2011","journal-title":"J Biol Chem"},{"key":"key20200714085828_b17-ol-0-0-10029","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/S0014-5793(01)02728-4","article-title":"The anti-apoptotic protein BAG-3 is overexpressed in pancreatic cancer and induced by heat stress in pancreatic cancer cell lines","volume":"503","author":"Liao","year":"2001","journal-title":"FEBS Lett"},{"key":"key20200714085828_b18-ol-0-0-10029","doi-asserted-by":"publisher","first-page":"508","DOI":"10.4161\/cbt.2.5.524","article-title":"BAG3 protein regulates cell survival in childhood acute lymphoblastic leukemia cells","volume":"2","author":"Romano","year":"2003","journal-title":"Cancer Biol Ther"},{"key":"key20200714085828_b19-ol-0-0-10029","doi-asserted-by":"publisher","first-page":"1159","DOI":"10.1210\/jc.2006-1712","article-title":"The antiapoptotic protein BAG3 is expressed in thyroid carcinomas and modulates apoptosis mediated by tumor necrosis factor-related apoptosis-inducing ligand","volume":"92","author":"Chiappetta","year":"2007","journal-title":"J Clin Endocrinol Metab"},{"key":"key20200714085828_b20-ol-0-0-10029","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1007\/s13277-010-0055-3","article-title":"BAG3 protein delocalisation in prostate carcinoma","volume":"31","author":"Staibano","year":"2010","journal-title":"Tumour Biol"},{"key":"key20200714085828_b21-ol-0-0-10029","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1016\/j.febslet.2008.12.032","article-title":"BAG3 gene silencing sensitizes leukemic cells to Bortezomib-induced apoptosis","volume":"583","author":"Liu","year":"2009","journal-title":"FEBS Lett"},{"key":"key20200714085828_b22-ol-0-0-10029","doi-asserted-by":"publisher","first-page":"4178","DOI":"10.1182\/blood-2006-04-016907","article-title":"Role of phosphatidylinositol 3\u2032-kinase\/AKT pathway in diffuse large B-cell lymphoma survival","volume":"108","author":"Uddin","year":"2006","journal-title":"Blood"},{"key":"key20200714085828_b23-ol-0-0-10029","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1186\/1475-2867-13-48","article-title":"Blockade of PI3K\/AKT pathway enhances sensitivity of Raji cells to chemotherapy through down-regulation of HSP70","volume":"13","author":"Fang","year":"2013","journal-title":"Cancer Cell Int"},{"key":"key20200714085828_b24-ol-0-0-10029","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1016\/S1368-7646(02)00120-6","article-title":"Activation of the PI3K\/Akt pathway and chemotherapeutic resistance","volume":"5","author":"West","year":"2002","journal-title":"Drug Resist Updat"},{"key":"key20200714085828_b25-ol-0-0-10029","doi-asserted-by":"publisher","first-page":"560","DOI":"10.1111\/j.1365-2141.2010.08123.x","article-title":"High immunohistochemical expression of p-AKT predicts inferior survival in patients with diffuse large B-cell lymphoma treated with immunochemotherapy","volume":"149","author":"Hasselblom","year":"2010","journal-title":"Br J Haematol"},{"key":"key20200714085828_b26-ol-0-0-10029","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1002\/jcp.21634","article-title":"Proteasome inhibitor MG132 induces BAG3 expression through activation of heat shock factor 1","volume":"218","author":"Du","year":"2009","journal-title":"J Cell Physiol"},{"key":"key20200714085828_b27-ol-0-0-10029","doi-asserted-by":"publisher","first-page":"e1692","DOI":"10.1038\/cddis.2014.584","article-title":"NIK is required for NF-\u03baB-mediated induction of BAG3 upon inhibition of constitutive protein degradation pathways","volume":"6","author":"Rapino","year":"2015","journal-title":"Cell Death Dis"},{"key":"key20200714085828_b28-ol-0-0-10029","doi-asserted-by":"publisher","first-page":"1405","DOI":"10.1111\/j.1476-5381.2009.00455.x","article-title":"Inhibition of the JNK signalling pathway enhances proteasome inhibitor-induced apoptosis of kidney cancer cells by suppression of BAG3 expression","volume":"158","author":"Wang","year":"2009","journal-title":"Br J Pharmacol"},{"key":"key20200714085828_b29-ol-0-0-10029","doi-asserted-by":"publisher","first-page":"482","DOI":"10.1007\/s12185-011-0821-z","article-title":"Antitumor activity and drug interactions of proteasome inhibitor Bortezomib in human high-risk myelodysplastic syndrome cells","volume":"93","author":"Huang","year":"2011","journal-title":"Int J Hematol"},{"key":"key20200714085828_b30-ol-0-0-10029","doi-asserted-by":"publisher","first-page":"11121","DOI":"10.1074\/jbc.M806268200","article-title":"Bortezomib overcomes tumor necrosis factor-related apoptosis-inducing ligand resistance in hepatocellular carcinoma cells in part through the inhibition of the phosphatidylinositol 3-kinase\/Akt pathway","volume":"284","author":"Chen","year":"2009","journal-title":"J Biol Chem"},{"key":"key20200714085828_b31-ol-0-0-10029","doi-asserted-by":"publisher","first-page":"967","DOI":"10.1002\/ijc.26096","article-title":"Inhibition of activated receptor tyrosine kinases by Sunitinib induces growth arrest and sensitizes melanoma cells to Bortezomib by blocking Akt pathway","volume":"130","author":"Yeramian","year":"2012","journal-title":"Int J Cancer"},{"key":"key20200714085828_b32-ol-0-0-10029","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/S1054-3589(08)57003-7","article-title":"The development and pharmacology of proteasome inhibitors for the management and treatment of cancer","volume":"57","author":"Ruggeri","year":"2009","journal-title":"Adv Pharmacol"},{"key":"key20200714085828_b33-ol-0-0-10029","doi-asserted-by":"publisher","first-page":"4285","DOI":"10.2741\/3005","article-title":"Proteasome inhibitors: A therapeutic strategy for haematological malignancy","volume":"13","author":"Crawford","year":"2008","journal-title":"Front Biosci"},{"key":"key20200714085828_b34-ol-0-0-10029","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1080\/07853890410029031","article-title":"The role of proteasome inhibitors in solid tumors","volume":"36","author":"Park","year":"2004","journal-title":"Ann Med"},{"key":"key20200714085828_b35-ol-0-0-10029","doi-asserted-by":"publisher","first-page":"4978","DOI":"10.1158\/1078-0432.CCR-09-3293","article-title":"A proteasome inhibitor, bortezomib, inhibits breast cancer growth and reduces osteolysis by downregulating metastatic genes","volume":"16","author":"Jones","year":"2010","journal-title":"Clin Cancer Res"},{"key":"key20200714085828_b36-ol-0-0-10029","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1038\/nrclinonc.2016.206","article-title":"Proteasome inhibitors in cancer therapy","volume":"14","author":"Manasanch","year":"2017","journal-title":"Nat Rev Clin Oncol"},{"key":"key20200714085828_b37-ol-0-0-10029","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1146\/annurev.pharmtox.46.120604.141300","article-title":"The proteasome and proteasome inhibitors in cancer therapy","volume":"46","author":"Voorhees","year":"2006","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"key20200714085828_b38-ol-0-0-10029","doi-asserted-by":"publisher","first-page":"415","DOI":"10.3109\/10428194.2013.806799","article-title":"Bortezomib inhibits proteasomal degradation of I\u03baB\u03b1 and induces mitochondrial dependent apoptosis in activated B-cell diffuse large B-cell lymphoma","volume":"55","author":"Bu","year":"2014","journal-title":"Leuk Lymphoma"},{"key":"key20200714085828_b39-ol-0-0-10029","doi-asserted-by":"publisher","first-page":"6069","DOI":"10.1182\/blood-2009-01-199679","article-title":"Differential efficacy of bortezomib plus chemotherapy within molecular subtypes of diffuse large B-cell lymphoma","volume":"113","author":"Dunleavy","year":"2009","journal-title":"Blood"},{"key":"key20200714085828_b40-ol-0-0-10029","doi-asserted-by":"publisher","first-page":"4094","DOI":"10.1158\/1078-0432.CCR-09-2882","article-title":"Combination therapy of bortezomib with novel targeted agents: an emerging treatment strategy","volume":"16","author":"Wright","year":"2010","journal-title":"Clin Cancer Res"},{"key":"key20200714085828_b41-ol-0-0-10029","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1111\/bjh.12206","article-title":"The Bruton tyrosine kinase (BTK) inhibitor PCI-32765 synergistically increases proteasome inhibitor activity in diffuse large-B cell lymphoma (DLBCL) and mantle cell lymphoma (MCL) cells sensitive or resistant to bortezomib","volume":"161","author":"Dasmahapatra","year":"2013","journal-title":"Br J Haematol"},{"key":"key20200714085828_b42-ol-0-0-10029","doi-asserted-by":"publisher","first-page":"3465","DOI":"10.1002\/cncr.29502","article-title":"A phase 2 study of weekly temsirolimus and bortezomib for relapsed or refractory B-cell non-Hodgkin lymphoma: A wisconsin oncology network study","volume":"121","author":"Fenske","year":"2015","journal-title":"Cancer"},{"key":"key20200714085828_b43-ol-0-0-10029","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1080\/10428194.2016.1190968","article-title":"Novel phosphatidylinositol 3-kinase inhibitor BKM120 enhances the sensitivity of multiple myeloma to bortezomib and overcomes resistance","volume":"58","author":"Yu","year":"2017","journal-title":"Leuk Lymphoma"},{"key":"key20200714085828_b44-ol-0-0-10029","first-page":"401","article-title":"Synergistic suppression of the PI3K inhibitor CAL-101 with bortezomib on mantle cell lymphoma growth","volume":"12","author":"Qu","year":"2015","journal-title":"Cancer Biol Med"},{"key":"key20200714085828_b45-ol-0-0-10029","doi-asserted-by":"publisher","first-page":"557","DOI":"10.3892\/ijo.2013.2205","article-title":"Dual targeting of glioblastoma multiforme with a proteasome inhibitor (Velcade) and a phosphatidylinositol 3-kinase inhibitor (ZSTK474)","volume":"44","author":"Lin","year":"2014","journal-title":"Int J Oncol"},{"key":"key20200714085828_b46-ol-0-0-10029","doi-asserted-by":"publisher","first-page":"912","DOI":"10.1016\/j.leukres.2012.02.010","article-title":"The dual PI3K and mTOR inhibitor NVP-BEZ235 exhibits anti-proliferative activity and overcomes bortezomib resistance in mantle cell lymphoma cells","volume":"36","author":"Kim","year":"2012","journal-title":"Leuk Res"},{"key":"key20200714085828_b47-ol-0-0-10029","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1002\/jcp.21397","article-title":"Bag3 gene expression is regulated by heat shock factor 1","volume":"215","author":"Franceschelli","year":"2008","journal-title":"J Cell Physiol"}],"container-title":["Oncology Letters"],"original-title":[],"deposited":{"date-parts":[[2020,7,14]],"date-time":"2020-07-14T09:48:14Z","timestamp":1594720094000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.spandidos-publications.com\/10.3892\/ol.2019.10029"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,2,8]]},"references-count":47,"URL":"https:\/\/doi.org\/10.3892\/ol.2019.10029","relation":{},"ISSN":["1792-1074","1792-1082"],"issn-type":[{"value":"1792-1074","type":"print"},{"value":"1792-1082","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,2,8]]}}}